This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Korea Research Institute of Chemical Technology, Snu Rdb Foundation. Active years: 1997-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Chungchongbuk-do, KR (1997)
- Chungcheongbukdo, KR (2001 - 2017)
Company Filing History:
4 out of 655 
1 out of 549 
Years Active: 1997-2017
Title: Innovations and Contributions of Jong Hwan Song
Introduction
Jong Hwan Song is a notable inventor based in Chungcheongbuk-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for treating various diseases. With a total of four patents to his name, his work has the potential to impact the medical community significantly.
Latest Patents
Among his latest patents, Jong Hwan Song has developed two key innovations. The first patent involves novel 2,4-pyrimidine derivatives that are effective for systemic lupus erythematosus (SLE). This invention includes a composition for preventing and treating SLE, utilizing materials that inhibit the surface translocation of gp96. The second patent focuses on 7-(3',4'-dialkoxyphenyl)[1,2,4]-triazolo[1,5-A]pyrimidine compounds. This invention provides a process for preparing these compounds and pharmaceutical compositions aimed at treating or preventing inflammatory diseases, including asthma, chronic obstructive pulmonary disease, and degenerative brain diseases.
Career Highlights
Jong Hwan Song has worked with esteemed organizations such as the Korea Research Institute of Chemical Technology and the Snur & Db Foundation. His experience in these institutions has allowed him to refine his research skills and contribute to significant advancements in chemical technology and pharmaceuticals.
Collaborations
Throughout his career, Jong Hwan Song has collaborated with notable colleagues, including Dong Ju Jeon and Eung K Ryu. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Jong Hwan Song's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work has the potential to provide new therapeutic options for patients suffering from various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile